Cellares and GenomeFrontier to assess automated GF-CART01 production
The partnership aims to assist GenomeFrontier’s clinical activities for GF-CART01 in the US.
Drug Development
Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy
Gilead and PAHO agree to expedite lenacapavir access for HIV prevention
Eli Lilly and QurCan sign genetic medicine deal
Cheplapharm to take over 20 medicines and three sites from Sanofi
FDA reduces monitoring time for Amgen’s Imdelltra infusions
Exegenesis Bio and Modalis sign research deal for Duchenne therapy
ABEC to expand global manufacturing network with new Wilson facility
